Beam Therapeutics
A Senior Program Manager role at Beam Therapeutics leading the BEAM-302 strategic gene editing program and serving as the program’s operational lead. The position partners closely with the Program Lead to align strategy and execution across drug discovery, development, manufacturing, clinical, CMC, and regulatory functions. The role is focused on driving program delivery, integration, and operational excellence within a biotechnology organization.
Headquarters
Cambridge, Massachusetts, United States
Company Size
501-1000 employees
Founded
2017
Beam Therapeutics is a clinical-stage biotechnology company based in Cambridge, MA, pioneering precision genetic medicines using its proprietary base editing platform to make precise single‑base DNA changes without creating double‑strand breaks. The company advances both in vivo and ex vivo programs across hematology, rare genetic diseases, and oncology, moving several candidates toward clinical development. Beam combines engineered editors, delivery technologies, and extensive safety profiling to create durable, potentially one‑time treatments and partners with academic and industry collaborators to accelerate translation.
Beam Therapeutics Stock Surges 23% in 6 Months: What's Driving It?
10 hours ago
Beam Therapeutics (BEAM) Leverages New Financing And IP Control Is Its Gene-Editing Edge Strengthening?
3 days ago
Beam Therapeutics Announces $500 Million Strategic Financing Facility with Sixth Street
2 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Beam Therapeutics.
After gene therapy exit, Pfizer locks in global license for Beam gene editing candidate
2 weeks ago
Associate Director, CMC Project Management
ORIC Pharmaceuticals Inc
Senior Manager, Program Management
CRISPR Therapeutics
Associate Director, Regulatory CMC
Eli Lilly and Company
Senior Director, Program & Portfolio Management
Vera Therapeutics, Inc.
Senior Director, CMC Regulatory Affairs
allogene
Director, CMC Technical Program Management
Perspective Therapeutics